After GSK replaced a popular asthma inhaler with an identical product at a higher price, families reported substantial ...

Move comes 2 years after controversial exit of brand-name product ...

Phase 4 trial data demonstrate that switching to budesonide–formoterol relievers effectively lowers FeNO in asthma with high baseline inflammation. Budesonide–formoterol reliever therapy significantly ...

cGuy's Severe Asthma Centre, Guy's Hospital, School of Immunology & Microbial Sciences, King's College London, London, UK dDivision of Pulmonary & Critical Care Medicine, University of Michigan, Ann ...

CLINICAL QUESTION: Is as-needed albuterol-budesonide superior to albuterol alone in patients with mild asthma? BACKGROUND: Although patients with mild asthma are often considered low risk, they still ...

Arjun Mohan received funding from Verona Pharm LLC and Regeneron Pharm for Consulting Services (one time, relationship has ended). These services have no conflict with the article written here ...

Depemokimab-ulaa (Exdensur) is approved for severe asthma with an eosinophilic phenotype, offering protection with just two doses annually. Phase 3 trials demonstrated significant reductions in asthma ...

Please provide your email address to receive an email when new articles are posted on . Patients had mild asthma and uncontrolled symptoms. Doses included an albuterol-budesonide combination or ...

As new trial findings show significant reductions in paediatric asthma attacks from a budesonide-formoterol 2-in-1 reliever therapy, Professor Andy Bush speaks to Saša Janković about the system ...

People with severe asthma sometimes rely on daily steroid pills, which raise the risk of diabetes, infections and bone problems. Now, a study supports the idea that a monthly antibody injection is a ...

New Yorkers with asthma may soon be able to breathe a little easier. Gov. Kathy Hochul signed legislation Monday that will make inhalers free for many New Yorkers starting in 2027. Under the new law, ...